Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

27-06-2015

Cultural adaptation and validation of the Chinese version of the Fatigue Severity Scale in patients with major depressive disorder and nondepressive people

Auteurs: Mei-Yeh Wang, I-Chao Liu, Chen-Huan Chiu, Pei-Shan Tsai

Gepubliceerd in: Quality of Life Research | Uitgave 1/2016

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The aims of the study were to adapt the Fatigue Severity Scale to Chinese conditions and assess the psychometric properties of the Chinese version in patients with major depressive disorder (MDD) and nondepressive people.

Methods

A total of 101 patients with MDD and 94 nondepressive persons were included in this study. A forward and backward translation procedure was performed for developing a culturally acceptable Chinese version of the Fatigue Severity Scale (CFSS). Validity was assessed according to construct validity, internal consistency, concurrent validity, divergent validity, and contrasted-group validity.

Results

The CFSS exhibited a one-factor structure in patients with MDD and the nondepressive participants. A 7-item version of CFSS and an 8-item version of the CFSS demonstrated better model fit than the original 9-item version in the patients with MDD and the nondepressive participants, respectively. In both participant groups, internal consistency values were within acceptable ranges. In addition, concurrent validity and divergent validity were confirmed in both groups. The average CFSS score of patients with MDD was significantly higher than that of the nondepressive participants.

Conclusion

The 9-item CFSS is a valid instrument for assessing fatigue-related impairment in Chinese-speaking patients with MDD. However, the two reduced-item CFSS versions showed better psychometric properties than the original version in the patients with MDD and the nondepressive participants.
vorige artikel Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers)
volgende artikel Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Addington, A. M., Gallo, J. J., Ford, D. E., & Eaton, W. W. (2001). Epidemiology of unexplained fatigue and major depression in the community: The Baltimore ECA follow-up, 1981-1994. Psychological Medicine, 31(6), 1037–1044.PubMedCrossRef
2.
van’t Leven, M., Zielhuis, G. A., van der Meer, J. W., Verbeek, A. L., & Bleijenberg, G. (2010). Fatigue and chronic fatigue syndrome-like complaints in the general population. European Journal of Public Health, 20(3), 251–257. doi:10.​1093/​eurpub/​ckp113.CrossRef
3.
Watanabe, N., Stewart, R., Jenkins, R., Bhugra, D. K., & Furukawa, T. A. (2008). The epidemiology of chronic fatigue, physical illness, and symptoms of common mental disorders: A cross-sectional survey from the second British National Survey of Psychiatric Morbidity. Journal of Psychosomatic Research, 64(4), 357–362. doi:10.​1016/​j.​jpsychores.​2007.​12.​003.PubMedCrossRef
4.
5.
Yu, D. S., & Lee, D. T. (2012). Do medically unexplained somatic symptoms predict depression in older Chinese? International Journal of Geriatric Psychiatry, 27(2), 119–126. doi:10.​1002/​gps.​2692.PubMedCrossRef
6.
7.
Demyttenaere, K., De, F. J., & Stahl, S. M. (2005). The many faces of fatigue in major depressive disorder. The International Journal of Neuropsychopharmacology, 8(1), 93–105.PubMedCrossRef
8.
Tylee, A., Gastpar, M., Lepine, J. P., & Mendlewicz, J. (1999). DEPRES II (Depression Research in European Society II): A patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. International Clinical Psychopharmacology, 14(3), 139–151.PubMedCrossRef
9.
Swindle, R., Kroenke, K., & Braun, L. A. (2001). Energy and improved workplace productivity in depression. Investing in Health: The Social and Economic Benefits of Health Care Innovation, 14, 323–341.
10.
Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995). Residual symptoms after partial remission: An important outcome in depression. Psychological Medicine, 25, 1171–1180.PubMedCrossRef
11.
12.
Fava, M., Ball, S., Nelson, J. C., Sparks, J., Konechnik, T., Classi, P., & Dube, S. (2014). Thase MEClinical relevance of fatigue as a residual symptom in major depressive disorder. Depression and Anxiety, 31(3), 250–257. doi:10.​1002/​da.​22199.PubMedCrossRef
13.
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., et al. (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology, 31(9), 1841–1853.PubMedCrossRef
14.
Lam, R. W., Michalak, E. E., Bond, D. J., Tam, E. M., Axler, A., & Yatham, L. N. (2012). Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depression Research and Treatment. doi:10.​1155/​2012/​630206.
15.
16.
17.
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. (2003). Brain circuits determine destiny in depression: A novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. Journal of Clinical Psychiatry, 64(14 Suppl), 6–17.
18.
Menza, M., Marin, H., & Opper, R. S. (2003). Residual symptoms in depression: Can treatment be symptom-specific? Journal of Clinical Psychiatry, 64(5), 516–523.PubMedCrossRef
19.
Marin, H., & Menza, M. A. (2005). The management of fatigue in depressed patients. Essential Psychopharmacology, 6(4), 185–192.PubMed
20.
Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.PubMedCrossRef
21.
Lerdal, A., Wahl, A., Rustøen, T., Hanestad, B. R., & Moum, T. (2005). Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scandianvian Journal of Public Health, 33(2), 123–130.CrossRef
22.
Mattsson, M., Moller, B., Lundberg, I., Gard, G., & Bostrom, C. (2008). Reliability and validity of the Fatigue Severity Scale in Swedish for patients with systemic lupus erythematosus. Scandianvian Journal of Rheumatology. doi:10.​1080/​0300974080191486​8.
23.
Kleinman, L., Zodet, M. W., Hakim, Z., Aledort, J., Barker, C., Chan, K., et al. (2000). Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Quality of Life Research, 9(5), 499–508.PubMedCrossRef
24.
Stone, P., Richards, M., A’Hern, R., & Hardy, J. (2000). A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Annals of Oncology, 11(5), 561–567.PubMedCrossRef
25.
26.
Abe, K., Takanashi, M., & Yanagihara, T. (2000). Fatigue in patients with Parkinson’s disease. Behavioural Neurology, 12(3), 103–106.PubMedCrossRef
27.
Fava, M., Thase, M. E., DeBattista, C., Doghramji, K., Arora, S., & Hughes, R. J. (2007). Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Annals of Clinical Psychiatry, 19(3), 153–159.PubMedCrossRef
28.
Ninan, P. T., Hassman, H. A., Glass, S. J., & McManus, F. C. (2004). Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. Journal of Clinical Psychiatry, 65(3), 414–420.PubMedCrossRef
29.
Schwartz, T. L., Azhar, N., Cole, K., Hopkins, G., Nihalani, N., Simionescu, M., et al. (2004). An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. Journal of Clinical Psychiatry, 65(9), 1223–1227.PubMedCrossRef
30.
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., Dikeos, D., & Lykouras, L. (2011). Psychometric evaluation of the Fatigue Severity Scale in patients with major depression. Quality of Life Research. doi:10.​1007/​s11136-010-9769-3.PubMed
31.
Ferentinos, P., Kontaxakis, V., Havaki-Kontaxaki, B., Paplos, K., & Soldatos, C. (2007). The measurement of fatigue in depression. Psychopathology. doi:10.​1159/​000098494.PubMed
32.
Lim, A. Y., Lee, A. R., Hatim, A., Tian-Mei, S., Liu, C. Y., Jeon, H. J., et al. (2014). Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries. BMC Psychiatry. doi:10.​1186/​1471-244X-14-37.
33.
Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: a practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56(2), 157–170.PubMedCrossRef
34.
Harris, R. J. (1985). A primer of multivariate statistics (2nd ed.). New York: Academic Press.
35.
Wilson, C. R., Voorhis, V., & Morgan, B. L. (2007). Understanding power and rules of thumb for determining sample sizes. Tutorials in Quantitative Methods for Psychology, 3, 43–50.
36.
Beck, A. T., Steer, R. A., & Brown, K. B. (1996). Beck depression inventory (2nd ed.). Boston: Harcourt Brace.
37.
Lu, A. L., Che, H. H., Chang, S. W., & Shen, W. W. (2002). Reliability and validity of the Chinese version of the Beck depression inventory II. Taiwanese Psychiatry, 36, 301–310.
38.
Yeung, A., Howarth, S., Chan, R., Sonawalla, S., Nierenberg, A. A., & Fava, M. (2002). Use of the Chinese version of the Beck depression inventory for screening depression in primary care. The Journal of Nervous and Mental Disease, 190(2), 94–99.PubMedCrossRef
39.
Lu, J. F. R., Tseng, H. M., & Tsai, Y. J. (2003). Assessment of health-related quality of life in Taiwan (I): Development and psychometric testing of SF-36 Taiwan version. Taiwan Journal of Public Health, 22, 501–511. [in Chinese].
40.
Tseng, H. M., Lu, J. F. R., & Tsai, Y. J. (2003). Assessment of health-related quality of life (II): Norming and validation of SF-36 Taiwan version. Taiwan Journal of Public Health, 22, 512–518. [in Chinese].
41.
Johnson, T. P. (1998). Approaches to equivalence in cross-cultural and cross-national survey research. ZUMA-Nachrichten Spezia, 3, 1–40.
42.
Ho, S. M. Y., Rochelle, T. L., Law, L. S. C., Duan, W., Bai, Y., & Shih, S. M. (2014). Methodological issues in positive psychology research with diverse populations: Exploring strengths among Chinese adults. Perspectives on the Intersection of Multiculturalism and Positive Psychology, Cross-Cultural Advancements in Positive Psychology. doi:10.​1007/​978-94-017-8654-6_​4.
43.
Hair, J. F., Anderson, R. E., Tatham, R. L., & Black, W. C. (2009). Multivariate data analysis (7th ed.). Englewood Cliffs, NJ: Prentice-Hall.
44.
Hooper, D., Coughlan, J., & Mullen, M. R. (2008). Structural equation modelling: Guidelines for determining model fit. The Electronic Journal of Business Research Methods, 6, 53–60.
45.
Terwee, C., Bot, S., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60, 34–42.PubMedCrossRef
46.
47.
Mielck, A., Reitmeir, P., Vogelmann, M., & Leidl, R. (2013). Impact of educational level on health-related quality of life (HRQL): Results from Germany based on the EuroQol 5D (EQ-5D). European Journal of Public Health. doi:10.​1093/​eurpub/​ckr206.
48.
Winter, Y., Epifanova-Bertschi, N., Sankowski, R., Zhukova, T. V., Oertel, W. H., Dodel, R., et al. (2012). Health-related quality of life and its determinants in the urban Russian population with major depressive disorder: A cross-sectional study. International Journal of Psychiatry in Medicine, 43(1), 35–49.PubMedCrossRef
49.
50.
Lerdal, A., Kottorp, A., Gay, C., Aouizerat, B. E., Portillo, C. J., & Lee, K. A. (2011). A 7-item version of the fatigue severity scale has better psychometric properties among HIV-infected adults: An application of a Rasch model. Quality of Life Research. doi:10.​1007/​s11136-011-9877-8.PubMedCentral
51.
52.
Burger, H., Franchignon, F., Puzic, N., & Giordano, A. (2010). Psychometric properties of the Fatigue Severity Scale in polio survivors. International Journal of Rehabilitation Research. doi:10.​1097/​MRR.​0b013e32833d6efb​.
Metagegevens
Titel
Cultural adaptation and validation of the Chinese version of the Fatigue Severity Scale in patients with major depressive disorder and nondepressive people
Auteurs
Mei-Yeh Wang
I-Chao Liu
Chen-Huan Chiu
Pei-Shan Tsai
Publicatiedatum
27-06-2015
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 1/2016
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-1056-x

Andere artikelen Uitgave 1/2016

Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review

  • Open Access
  • Review Paper

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers)

Validation of the Italian version of the Oxford Ankle Foot Questionnaire for children

  • Brief Communication

Development of an item bank for computerized adaptive test (CAT) measurement of pain

How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations

Evaluating quality of life outcomes following joint replacement: psychometric evaluation of a short form of the WHOQOL-Bref